Latanoprost for glaucoma: primum non nocere - Authors' reply.
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK. Electronic address: david.garway-heath@moorfields.nhs.uk.
David F
DF
Garway-Heath
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK.
Catey
C
Bunce
Norfolk and Norwich University Hospital, Norfolk, UK.
David C
DC
Broadway
Addenbrooke's Hospital, Cambridge, UK.
Keith R
KR
Martin
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK.
Gerassimos
G
Lascaratos
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK.
Richard P
RP
Wormald
D000959:Antihypertensive Agents / Q000008:administration & dosage*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic